Moving a biopharmaceutical product from molecule to market is demanding in terms of expertise and capabilities needed throughout the development and manufacturing process.
In this white paper, we explore the processes, operations, and value of Emergent CDMO's integrated internal teams, which cultivate efficient organization alongside smooth and timely technology transfer and scale-up, from R&D to GMP manufacturing.
Download our latest white paper to learn how partnering with an integrated CDMO can help create an efficient development services framework to achieve your drug substance and drug product manufacturing goals.
